Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Positron-Emission Tomography | 21 | 2024 | 6550 | 1.280 |
Why?
|
Granzymes | 2 | 2024 | 277 | 1.010 |
Why?
|
Receptors, Somatostatin | 2 | 2018 | 138 | 0.970 |
Why?
|
Radiopharmaceuticals | 11 | 2025 | 2702 | 0.900 |
Why?
|
Fluorodeoxyglucose F18 | 8 | 2024 | 2028 | 0.830 |
Why?
|
Neuroendocrine Tumors | 2 | 2023 | 659 | 0.810 |
Why?
|
Octreotide | 3 | 2023 | 156 | 0.750 |
Why?
|
Organometallic Compounds | 2 | 2023 | 648 | 0.740 |
Why?
|
Urologic Neoplasms | 1 | 2023 | 312 | 0.630 |
Why?
|
Cholangiocarcinoma | 1 | 2021 | 561 | 0.490 |
Why?
|
Gallium Radioisotopes | 4 | 2024 | 195 | 0.460 |
Why?
|
Mice, Nude | 8 | 2024 | 3618 | 0.420 |
Why?
|
Fibrin | 2 | 2024 | 514 | 0.380 |
Why?
|
Esophageal Neoplasms | 4 | 2015 | 1661 | 0.380 |
Why?
|
Intestinal Neoplasms | 1 | 2013 | 314 | 0.360 |
Why?
|
Hemophilia A | 3 | 2009 | 359 | 0.350 |
Why?
|
Etidronic Acid | 1 | 2010 | 63 | 0.350 |
Why?
|
Artificial Intelligence | 2 | 2024 | 2666 | 0.350 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2024 | 2441 | 0.330 |
Why?
|
Antineoplastic Agents, Hormonal | 3 | 2015 | 1536 | 0.320 |
Why?
|
Prostatic Neoplasms | 5 | 2024 | 11097 | 0.320 |
Why?
|
Cell Adhesion Molecules | 1 | 2015 | 1612 | 0.320 |
Why?
|
Stomach Neoplasms | 3 | 2024 | 1481 | 0.310 |
Why?
|
Molecular Imaging | 4 | 2023 | 822 | 0.310 |
Why?
|
Tumor Microenvironment | 3 | 2023 | 3944 | 0.300 |
Why?
|
Osteogenesis, Distraction | 1 | 2010 | 233 | 0.290 |
Why?
|
Estradiol | 1 | 2015 | 1951 | 0.290 |
Why?
|
Bone Regeneration | 1 | 2010 | 437 | 0.280 |
Why?
|
Molecular Targeted Therapy | 2 | 2018 | 2824 | 0.280 |
Why?
|
Accidents, Traffic | 2 | 2010 | 818 | 0.280 |
Why?
|
Lower Extremity | 3 | 2010 | 1217 | 0.280 |
Why?
|
Pancreatic Neoplasms | 3 | 2024 | 5446 | 0.270 |
Why?
|
Wounds, Penetrating | 1 | 2009 | 316 | 0.270 |
Why?
|
Receptors, Estrogen | 1 | 2015 | 2252 | 0.270 |
Why?
|
Intraoperative Care | 1 | 2010 | 768 | 0.270 |
Why?
|
Bone Resorption | 1 | 2010 | 726 | 0.260 |
Why?
|
Fracture Fixation, Intramedullary | 1 | 2008 | 160 | 0.260 |
Why?
|
Bronchial Arteries | 1 | 2025 | 23 | 0.240 |
Why?
|
Technetium Tc 99m Aggregated Albumin | 1 | 2025 | 68 | 0.240 |
Why?
|
Tibia | 1 | 2010 | 1075 | 0.230 |
Why?
|
Femoral Fractures | 1 | 2008 | 376 | 0.230 |
Why?
|
Yttrium Radioisotopes | 1 | 2025 | 116 | 0.220 |
Why?
|
Upper Extremity | 1 | 2009 | 684 | 0.220 |
Why?
|
Takayasu Arteritis | 1 | 2024 | 106 | 0.210 |
Why?
|
Spinal Fractures | 1 | 2010 | 710 | 0.210 |
Why?
|
Bone Density Conservation Agents | 1 | 2010 | 797 | 0.210 |
Why?
|
Neoplasm Transplantation | 2 | 2018 | 2012 | 0.210 |
Why?
|
Wounds, Nonpenetrating | 1 | 2009 | 807 | 0.200 |
Why?
|
Anemia, Hemolytic | 1 | 2023 | 164 | 0.190 |
Why?
|
Accidental Falls | 1 | 2010 | 1079 | 0.190 |
Why?
|
Cell Line, Tumor | 12 | 2024 | 17097 | 0.190 |
Why?
|
Mice | 18 | 2024 | 81912 | 0.190 |
Why?
|
Receptors, Peptide | 1 | 2023 | 280 | 0.190 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 2023 | 147 | 0.190 |
Why?
|
Collagen Type I | 1 | 2024 | 617 | 0.180 |
Why?
|
Cell Proliferation | 2 | 2014 | 10455 | 0.180 |
Why?
|
Copper Radioisotopes | 2 | 2024 | 99 | 0.180 |
Why?
|
Somatostatin | 1 | 2022 | 458 | 0.180 |
Why?
|
Giant Cell Arteritis | 1 | 2024 | 307 | 0.170 |
Why?
|
Animals | 23 | 2024 | 168965 | 0.170 |
Why?
|
Nuclear Medicine | 1 | 2023 | 262 | 0.170 |
Why?
|
Neoplasms, Experimental | 2 | 2016 | 1228 | 0.160 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2015 | 3608 | 0.160 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2024 | 1759 | 0.160 |
Why?
|
Critical Pathways | 1 | 2022 | 476 | 0.160 |
Why?
|
Humans | 52 | 2025 | 767040 | 0.160 |
Why?
|
Tumor Burden | 2 | 2023 | 1903 | 0.150 |
Why?
|
Mice, Inbred NOD | 1 | 2023 | 1837 | 0.150 |
Why?
|
Nephritis, Interstitial | 1 | 2019 | 157 | 0.150 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2024 | 521 | 0.150 |
Why?
|
Joint Deformities, Acquired | 2 | 2008 | 35 | 0.150 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2024 | 8940 | 0.140 |
Why?
|
Patient Care | 1 | 2022 | 628 | 0.140 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2021 | 2330 | 0.130 |
Why?
|
Embolization, Therapeutic | 2 | 2025 | 1403 | 0.130 |
Why?
|
Leukocytes, Mononuclear | 1 | 2023 | 1854 | 0.130 |
Why?
|
Ceramics | 1 | 2016 | 113 | 0.130 |
Why?
|
Methionine | 1 | 2018 | 570 | 0.130 |
Why?
|
Chitosan | 1 | 2016 | 138 | 0.120 |
Why?
|
Mesenchymal Stem Cells | 2 | 2018 | 1665 | 0.120 |
Why?
|
Heterocyclic Compounds, 1-Ring | 1 | 2015 | 68 | 0.120 |
Why?
|
Anus Neoplasms | 1 | 2019 | 336 | 0.120 |
Why?
|
Radionuclide Imaging | 2 | 2023 | 1987 | 0.120 |
Why?
|
Bone Substitutes | 1 | 2016 | 230 | 0.120 |
Why?
|
Genes, Reporter | 1 | 2018 | 1526 | 0.110 |
Why?
|
Iran | 4 | 2010 | 762 | 0.110 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2015 | 4049 | 0.110 |
Why?
|
Enzyme Activators | 1 | 2014 | 56 | 0.110 |
Why?
|
Chemical Fractionation | 1 | 2013 | 60 | 0.110 |
Why?
|
Feasibility Studies | 1 | 2025 | 5311 | 0.110 |
Why?
|
Silicates | 1 | 2013 | 49 | 0.110 |
Why?
|
Liver Neoplasms | 2 | 2021 | 4357 | 0.100 |
Why?
|
Glass | 1 | 2013 | 116 | 0.100 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2014 | 189 | 0.100 |
Why?
|
Range of Motion, Articular | 3 | 2008 | 1597 | 0.100 |
Why?
|
Fibrosis | 2 | 2024 | 2078 | 0.100 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2014 | 446 | 0.100 |
Why?
|
Ferrosoferric Oxide | 1 | 2014 | 348 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2016 | 563 | 0.100 |
Why?
|
Treatment Outcome | 12 | 2024 | 65295 | 0.100 |
Why?
|
Forecasting | 1 | 2021 | 2936 | 0.100 |
Why?
|
Lipogenesis | 1 | 2014 | 217 | 0.100 |
Why?
|
Acute Kidney Injury | 1 | 2024 | 1946 | 0.100 |
Why?
|
Disease Models, Animal | 6 | 2021 | 18330 | 0.100 |
Why?
|
Solubility | 1 | 2013 | 1078 | 0.100 |
Why?
|
Boron Compounds | 1 | 2013 | 195 | 0.090 |
Why?
|
Hemarthrosis | 2 | 2008 | 39 | 0.090 |
Why?
|
Contrast Media | 1 | 2024 | 5329 | 0.090 |
Why?
|
Tissue Distribution | 1 | 2015 | 2275 | 0.090 |
Why?
|
Lymphatic Metastasis | 1 | 2019 | 2900 | 0.090 |
Why?
|
Glioblastoma | 2 | 2018 | 3461 | 0.090 |
Why?
|
Esophagoscopy | 1 | 2012 | 398 | 0.090 |
Why?
|
Tennis Elbow | 1 | 2010 | 16 | 0.090 |
Why?
|
Subclavian Steal Syndrome | 1 | 2010 | 20 | 0.090 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2014 | 594 | 0.090 |
Why?
|
Brachiocephalic Trunk | 1 | 2010 | 40 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2013 | 10748 | 0.080 |
Why?
|
Radiography | 3 | 2010 | 6975 | 0.080 |
Why?
|
Injections, Intralesional | 1 | 2010 | 280 | 0.080 |
Why?
|
Male | 21 | 2025 | 364203 | 0.080 |
Why?
|
Fibroblasts | 2 | 2023 | 4167 | 0.080 |
Why?
|
Gastrointestinal Tract | 1 | 2015 | 837 | 0.080 |
Why?
|
Basilar Artery | 1 | 2010 | 207 | 0.080 |
Why?
|
Endarterectomy | 1 | 2009 | 196 | 0.080 |
Why?
|
Mice, Inbred C57BL | 3 | 2024 | 22361 | 0.080 |
Why?
|
Injections, Intramuscular | 1 | 2010 | 551 | 0.080 |
Why?
|
Cell Adhesion | 1 | 2015 | 3093 | 0.080 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2016 | 1621 | 0.080 |
Why?
|
Neoplasms | 3 | 2023 | 22350 | 0.080 |
Why?
|
Neuromuscular Agents | 1 | 2010 | 148 | 0.080 |
Why?
|
Biocompatible Materials | 1 | 2016 | 1690 | 0.080 |
Why?
|
Cubital Tunnel Syndrome | 1 | 2008 | 34 | 0.080 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2013 | 505 | 0.070 |
Why?
|
Computer Simulation | 1 | 2021 | 6260 | 0.070 |
Why?
|
ras Proteins | 1 | 2013 | 1054 | 0.070 |
Why?
|
Early Diagnosis | 1 | 2012 | 1188 | 0.070 |
Why?
|
Extracellular Matrix | 1 | 2015 | 1733 | 0.070 |
Why?
|
Breast Neoplasms | 1 | 2015 | 21178 | 0.070 |
Why?
|
Popliteal Artery | 1 | 2009 | 313 | 0.070 |
Why?
|
Bone Neoplasms | 1 | 2019 | 2563 | 0.070 |
Why?
|
Biopsy | 2 | 2021 | 6777 | 0.070 |
Why?
|
Neoplasm Invasiveness | 1 | 2015 | 3611 | 0.070 |
Why?
|
Arteriovenous Fistula | 1 | 2010 | 320 | 0.070 |
Why?
|
Tissue Engineering | 1 | 2016 | 1861 | 0.070 |
Why?
|
Botulinum Toxins, Type A | 1 | 2010 | 238 | 0.070 |
Why?
|
Aged | 13 | 2025 | 171319 | 0.070 |
Why?
|
Limb Salvage | 1 | 2009 | 488 | 0.070 |
Why?
|
Lung Neoplasms | 2 | 2025 | 13491 | 0.060 |
Why?
|
Tumor Cells, Cultured | 1 | 2013 | 6106 | 0.060 |
Why?
|
Immunotherapy | 1 | 2021 | 4745 | 0.060 |
Why?
|
Colorectal Neoplasms | 2 | 2016 | 6966 | 0.060 |
Why?
|
Arterial Occlusive Diseases | 1 | 2009 | 743 | 0.060 |
Why?
|
Humeral Fractures | 1 | 2008 | 283 | 0.060 |
Why?
|
Bone Diseases | 1 | 2009 | 416 | 0.060 |
Why?
|
Diabetic Foot | 1 | 2009 | 382 | 0.060 |
Why?
|
Elbow Joint | 1 | 2008 | 359 | 0.060 |
Why?
|
Blood Vessels | 1 | 2010 | 1110 | 0.060 |
Why?
|
Female | 17 | 2025 | 396660 | 0.060 |
Why?
|
Carpal Tunnel Syndrome | 1 | 2008 | 304 | 0.060 |
Why?
|
Prognosis | 5 | 2024 | 29963 | 0.060 |
Why?
|
Rabbits | 1 | 2010 | 4751 | 0.060 |
Why?
|
Hematoma | 1 | 2009 | 766 | 0.060 |
Why?
|
Glutamate Carboxypeptidase II | 1 | 2024 | 90 | 0.060 |
Why?
|
Middle Aged | 12 | 2025 | 223233 | 0.060 |
Why?
|
Ischemia | 2 | 2009 | 1905 | 0.060 |
Why?
|
Antineoplastic Agents | 2 | 2018 | 13650 | 0.050 |
Why?
|
Algorithms | 1 | 2024 | 14098 | 0.050 |
Why?
|
Retrospective Studies | 5 | 2024 | 81659 | 0.050 |
Why?
|
Protein Binding | 1 | 2015 | 9327 | 0.050 |
Why?
|
Lactate Dehydrogenases | 1 | 2022 | 26 | 0.050 |
Why?
|
Leucovorin | 1 | 2024 | 644 | 0.050 |
Why?
|
Knee Joint | 2 | 2008 | 1683 | 0.050 |
Why?
|
Hand | 1 | 2008 | 910 | 0.050 |
Why?
|
Osteotomy | 1 | 2007 | 837 | 0.050 |
Why?
|
Colitis, Ulcerative | 1 | 2014 | 1924 | 0.050 |
Why?
|
Toes | 1 | 2023 | 209 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 3 | 2024 | 36582 | 0.050 |
Why?
|
Hexokinase | 1 | 2022 | 124 | 0.050 |
Why?
|
Glucose Transporter Type 1 | 1 | 2022 | 186 | 0.050 |
Why?
|
Marmota | 1 | 2021 | 13 | 0.050 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11063 | 0.050 |
Why?
|
Receptor, erbB-3 | 1 | 2022 | 142 | 0.050 |
Why?
|
Lactates | 1 | 2022 | 398 | 0.050 |
Why?
|
Peptides | 1 | 2013 | 4348 | 0.050 |
Why?
|
Rats | 2 | 2016 | 23713 | 0.050 |
Why?
|
Pyruvic Acid | 1 | 2022 | 205 | 0.050 |
Why?
|
Femur | 1 | 2007 | 1321 | 0.050 |
Why?
|
Colonic Neoplasms | 1 | 2013 | 2535 | 0.050 |
Why?
|
Hemolysis | 1 | 2023 | 417 | 0.050 |
Why?
|
Adolescent | 6 | 2019 | 89046 | 0.040 |
Why?
|
Electromagnetic Phenomena | 1 | 2021 | 159 | 0.040 |
Why?
|
Antigens, Surface | 1 | 2024 | 1617 | 0.040 |
Why?
|
Lung Injury | 1 | 2024 | 432 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 3 | 2024 | 20741 | 0.040 |
Why?
|
Radiometry | 1 | 2025 | 818 | 0.040 |
Why?
|
Fluorouracil | 1 | 2024 | 1652 | 0.040 |
Why?
|
Length of Stay | 2 | 2010 | 6489 | 0.040 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2024 | 1142 | 0.040 |
Why?
|
Observer Variation | 1 | 2024 | 2616 | 0.040 |
Why?
|
Cross-Sectional Studies | 2 | 2010 | 26325 | 0.040 |
Why?
|
Child, Preschool | 3 | 2010 | 42606 | 0.040 |
Why?
|
Serine Endopeptidases | 1 | 2023 | 1027 | 0.040 |
Why?
|
Reproducibility of Results | 3 | 2024 | 20169 | 0.040 |
Why?
|
Adult | 10 | 2019 | 223317 | 0.040 |
Why?
|
Wounds and Injuries | 1 | 2010 | 2513 | 0.040 |
Why?
|
Adenocarcinoma | 1 | 2014 | 6360 | 0.030 |
Why?
|
Hemorrhage | 1 | 2009 | 3464 | 0.030 |
Why?
|
Evaluation Studies as Topic | 1 | 2019 | 1623 | 0.030 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 5389 | 0.030 |
Why?
|
Silicon Dioxide | 1 | 2016 | 217 | 0.030 |
Why?
|
Misonidazole | 1 | 2015 | 33 | 0.030 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2016 | 939 | 0.030 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2023 | 1677 | 0.030 |
Why?
|
Carbocyanines | 1 | 2014 | 177 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2022 | 2457 | 0.030 |
Why?
|
Postoperative Period | 1 | 2018 | 1824 | 0.030 |
Why?
|
Aged, 80 and over | 3 | 2019 | 59548 | 0.030 |
Why?
|
Neoplasm, Residual | 1 | 2018 | 1012 | 0.030 |
Why?
|
Materials Testing | 1 | 2016 | 870 | 0.030 |
Why?
|
Age Factors | 1 | 2010 | 18401 | 0.030 |
Why?
|
Thymidine Kinase | 1 | 2013 | 286 | 0.030 |
Why?
|
Ganciclovir | 1 | 2013 | 256 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2022 | 2428 | 0.030 |
Why?
|
Dimethyl Sulfoxide | 1 | 2014 | 250 | 0.030 |
Why?
|
Cell Hypoxia | 1 | 2015 | 661 | 0.030 |
Why?
|
Genes, APC | 1 | 2013 | 144 | 0.030 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2013 | 195 | 0.020 |
Why?
|
Point-of-Care Systems | 1 | 2021 | 1217 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2021 | 1592 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2019 | 14672 | 0.020 |
Why?
|
Young Adult | 4 | 2019 | 59980 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2022 | 3684 | 0.020 |
Why?
|
Indocyanine Green | 1 | 2014 | 237 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2013 | 9108 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2010 | 39317 | 0.020 |
Why?
|
Coloring Agents | 1 | 2014 | 565 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2024 | 11872 | 0.020 |
Why?
|
Osteoblasts | 1 | 2016 | 1145 | 0.020 |
Why?
|
Mice, Transgenic | 2 | 2014 | 9551 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2024 | 4052 | 0.020 |
Why?
|
Genes, p53 | 1 | 2013 | 711 | 0.020 |
Why?
|
Body Mass Index | 1 | 2008 | 13048 | 0.020 |
Why?
|
Simplexvirus | 1 | 2013 | 805 | 0.020 |
Why?
|
Gangrene | 1 | 2009 | 92 | 0.020 |
Why?
|
Acute Disease | 1 | 2019 | 7236 | 0.020 |
Why?
|
Paresis | 1 | 2010 | 177 | 0.020 |
Why?
|
Bone and Bones | 1 | 2019 | 2587 | 0.020 |
Why?
|
Mutation | 1 | 2013 | 30211 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2024 | 15424 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2013 | 1244 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2014 | 1969 | 0.020 |
Why?
|
Spleen | 1 | 2014 | 2292 | 0.020 |
Why?
|
Lactic Acid | 1 | 2013 | 1139 | 0.020 |
Why?
|
Forearm | 1 | 2010 | 427 | 0.020 |
Why?
|
Genetic Engineering | 1 | 2013 | 935 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2019 | 3468 | 0.020 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2014 | 888 | 0.020 |
Why?
|
Muscle Weakness | 1 | 2010 | 412 | 0.020 |
Why?
|
Hand Strength | 1 | 2010 | 466 | 0.020 |
Why?
|
Child | 3 | 2010 | 80771 | 0.020 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2010 | 291 | 0.020 |
Why?
|
Vascular Patency | 1 | 2010 | 915 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2014 | 2628 | 0.020 |
Why?
|
Down-Regulation | 1 | 2014 | 2931 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2023 | 7868 | 0.020 |
Why?
|
Wrist | 1 | 2008 | 231 | 0.020 |
Why?
|
Dexamethasone | 1 | 2014 | 1963 | 0.020 |
Why?
|
Saphenous Vein | 1 | 2009 | 519 | 0.020 |
Why?
|
Veins | 1 | 2010 | 769 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2013 | 2721 | 0.020 |
Why?
|
Constriction, Pathologic | 1 | 2009 | 1104 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 2014 | 1928 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2022 | 5693 | 0.020 |
Why?
|
Leukocytes | 1 | 2014 | 2034 | 0.020 |
Why?
|
Indoles | 1 | 2014 | 1836 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2016 | 8108 | 0.020 |
Why?
|
Obesity | 1 | 2008 | 13085 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2014 | 6226 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2014 | 2487 | 0.020 |
Why?
|
Arteries | 1 | 2010 | 1123 | 0.020 |
Why?
|
Immune Tolerance | 1 | 2014 | 2322 | 0.020 |
Why?
|
Fingers | 1 | 2008 | 508 | 0.010 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2013 | 2061 | 0.010 |
Why?
|
Angiography | 1 | 2009 | 1597 | 0.010 |
Why?
|
Endoscopy | 1 | 2014 | 1854 | 0.010 |
Why?
|
Cell Survival | 1 | 2013 | 5750 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2013 | 2883 | 0.010 |
Why?
|
Anthropometry | 1 | 2008 | 1345 | 0.010 |
Why?
|
Cell Line | 1 | 2016 | 15567 | 0.010 |
Why?
|
Urban Population | 1 | 2010 | 2044 | 0.010 |
Why?
|
Nanoparticles | 1 | 2014 | 1966 | 0.010 |
Why?
|
Pilot Projects | 1 | 2015 | 8732 | 0.010 |
Why?
|
Survival Analysis | 1 | 2014 | 10092 | 0.010 |
Why?
|
Glucose | 1 | 2013 | 4341 | 0.010 |
Why?
|
Exercise Therapy | 1 | 2007 | 939 | 0.010 |
Why?
|
Renal Dialysis | 1 | 2010 | 1790 | 0.010 |
Why?
|
Walking | 1 | 2007 | 1201 | 0.010 |
Why?
|
Prospective Studies | 1 | 2025 | 54886 | 0.010 |
Why?
|
Pain Measurement | 1 | 2010 | 3584 | 0.010 |
Why?
|
Genotype | 1 | 2013 | 13035 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2014 | 18989 | 0.010 |
Why?
|
Recovery of Function | 1 | 2008 | 2978 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2008 | 2647 | 0.010 |
Why?
|
Apoptosis | 1 | 2013 | 9513 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2014 | 9245 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2012 | 12986 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2009 | 8535 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2013 | 9532 | 0.010 |
Why?
|
Time Factors | 2 | 2009 | 40154 | 0.010 |
Why?
|
Chronic Disease | 1 | 2010 | 9362 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2010 | 4968 | 0.010 |
Why?
|
Sex Factors | 1 | 2008 | 10622 | 0.010 |
Why?
|
Logistic Models | 1 | 2008 | 13284 | 0.010 |
Why?
|
Comorbidity | 1 | 2008 | 10582 | 0.010 |
Why?
|
Signal Transduction | 1 | 2013 | 23621 | 0.010 |
Why?
|
Cohort Studies | 1 | 2008 | 41718 | 0.000 |
Why?
|
Risk Factors | 1 | 2008 | 74886 | 0.000 |
Why?
|